Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 3Other 1

Conditions

Obesity 12Sexual Dysfunction, Physiological 6Neoplasms 6Prostatic Neoplasms 4Lung Neoplasms 3Infertility 3Dyspnea 3Breast Neoplasms 3Wilms Tumor 2Urinary Incontinence 2Small Cell Lung Carcinoma 2Sarcoma 2Precursor Cell Lymphoblastic Leukemia-Lymphoma 2Polycystic Ovary Syndrome 2Osteosarcoma 2Neoplasm Metastasis 2Diabetes Mellitus 2Constipation 2Carcinoma, Non-Small-Cell Lung 2WAGR Syndrome 1Urogenital Abnormalities 1Thyroid Diseases 1Testicular Neoplasms 1Teratoma 1Spinal Cord Neoplasms 1Sezary Syndrome 1Sexuality 1Sarcoma, Kaposi 1Rhabdoid Tumor 1Prostatic Hyperplasia 1

Interventions

Metformin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NIH × Adenomatous Polyps × Other × Clear all
NCT01312467 2019-03-05

Trial of Metformin for Colorectal Cancer Risk Reduction for History of Colorectal Adenomas and Elevated BMI

National Cancer Institute (NCI)

Phase 2 Completed
45 enrolled 7 charts
GastrointestinalOther

Obesity, Colorectal Neoplasms, Adenomatous Polyps

Data powered by HemOnc (CC BY 4.0) Colophon âš¡